OSA, obstructive sleep apnea syndrome
Obstructive sleep apnea syndrome is one of the most common and dangerous diseases associated with sleep disorders. OSA is accompanied by loud snoring, sleep breathing stops for 10 seconds or more, excessive daytime sleepiness. As of early 2019, more than 100 million people worldwide are affected by the disease.
Content |
Main article: Human Son
In the absence of correct treatment, OSA can provoke various cardiological disorders, increases the risk of stroke. In addition, the danger of getting into an accident and getting industrial injuries increases, irritability, depressive states appear, and there is a decrease in the quality of life in general. It has been proven that the life expectancy of people who do not pay attention to the prevention of this disease is reduced by 15-20 years (data are given in accordance with the DALY index (DALY - the number of lost years of life as a result of premature death, as well as years lived with certain restrictions of health and body functions).
One method of prevention of OSA is CPAP therapy, which keeps the airways open and restores the normal level of oxygen saturation of the body.
Technologies
2023
A mouth-sticking device for the treatment of severe apnea has been released
On November 29, 2023, Vivos Therapeutics introduced the CARE series oral devices designed to treat severe obstructive sleep apnea (OSA). These products are an alternative to neurostimulation implants and IPAP therapy - artificial ventilation of the lungs with constant positive pressure. Read more here.
Swallowed sensor released to monitor sleep disorders
On November 17, 2023, US researchers at the Massachusetts Institute of Technology (MIT) announced the development of a swallowed VM Pill capsule to track vital signs of the body, such as breathing intensity and heart rate. A smart "pill" will help in monitoring sleep disorders and diagnosing potentially dangerous conditions. Read more here.
Joe Biden uses a machine to treat sleep apnea at night
On June 28, 2023, the White House announced that US President Biden began using a device at night to treat sleep apnea. This explains the traces on the face of the American leader, which the reporters began to notice.
It is noted that Biden uses the SIPAP device (CPAP): the principle of his work boils down to artificial lung ventilation with constant positive pressure. The president uses these devices to improve the quality of sleep - in particular, to combat apnea, that is, with multiple respiratory stops for more than 10 seconds. The SIPAP apparatus is a small compressor that supplies a constant flow of air at a certain pressure to the respiratory tract through the mask.
 | Since 2008, the president has disclosed cases of sleep apnea in detailed medical reports. Last night he used the SIPAP machine, which is usually for people with this condition, "said White House spokesman Andrew Bates. |  |
Medical data released in 2008 suggested that Biden had repeated cases of sleep apnea. A medical record released by the president's physician in 2019 noted that sleep apnea "was considered, but symptoms improved significantly after sinus and nasal surgeries." medical Biden's 2023 examination report made no mention of sleep apnea as a condition that afflicts the president. All the tests passed showed that he can hold the post of head. states
According to the American Medical Association, approximately 30 million Americans suffer from sleep apnea, although only 6 million US residents have been diagnosed with the disease. The problem is more common in men than in women. Many people with apnea use SIPAP devices.[1]
Inspire Medical Systems Gets Approval to Sell Obstructive Sleep Apnea Treatment Device
The company Inspire Medical Systems received American from the regulator () industries health care FDA an expanded permission to use its eponymous, which medical devices for the treatment of obstructive sleep apnea (CSA) should increase the circle of people who can apply such treatment. This became known on June 23, 2023. More. here
2021: Announcement of an implant for the treatment of a disease in which a person stops breathing in his sleep
In early August 2021, Zoll Medical released an implantable next-generation EL-X Remedē neurostimulation system for the treatment of severe sleep apnea, in which a person periodically stops breathing during sleep. Sleep apnea is a serious condition that can lead to the development of heart failure, coronary heart disease, and cardiac arrhythmia. Read more here.
2020: eXciteOSA announcement - snoring treatment systems
In early February 2021, Signifier Medical Technologies released a language simulator that treats snoring and sleep respiratory arrest problems by electrostimulating muscles. The eXciteOSA device, formerly SnooZeal, is equipped with a four-electrode mouthpiece. The electrodes provide electrical muscle stimulation similar to percutaneous electrical nerve stimulation but directed at the area around the tongue. Fortified tongue muscles will eventually impede airway closure, allowing air to freely enter and exit the lungs. Read more here.
See also
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |